Literature DB >> 26684635

Methylsulfonylmethane and boswellic acids versus glucosamine sulfate in the treatment of knee arthritis: Randomized trial.

Angela Notarnicola1, Giuseppe Maccagnano2, Lorenzo Moretti2, Vito Pesce2, Silvio Tafuri3, Alessandra Fiore2, Biagio Moretti4.   

Abstract

Until now glucosamine sulfate (GS) has been the most widely used supplement and has been shown to be efficacious in the treatment of osteoarthritis (OA). Methylsulfonylmethane (MSM) and boswellic acids (BA) are new effective supplements for the management of inflammation and joint degeneration, according to previous experimental studies. The aim of our study is to test the effectiveness of association of MSM and BA in comparison with GS in knee arthritis.In this prospective randomized clinical trial, MEBAGA (Methylsulfonylmethane and Boswellic Acids versus Glucosamine sulfate in the treatment of knee Arthritis), 120 participants affected by arthritis of the knee were randomly assigned to an experimental group (MB group) or a control group (GS group) treated for 60 days with 5 g of MSM and 7.2 mg of BA or with 1500 mg of GS daily, respectively. At the 2-month (T1) and 6-months (T2) follow-up , the efficacy of these two nutraceuticals was assessed using the visual analog pain scale (VAS) and the Lequesne Index (LI) for joint function, along with the use of anti-inflammatory drugs (non-steroidal anti-inflammatory drugs and anti-cyclooxygenase-2).The repeated measures ANOVA analysis shows that for VAS, LI, and the use of anti-inflammatory drugs scores there are improvements due to the time in the two groups (respectively, F=26.0; P<0.0001; F=4.15; P=0.02; F=3.38; P=0.04), with a tendency to better values for the MB group at T2.On the basis of these preliminary data, we could support the efficacy of the MSM in association with BA in the treatment of OA. These results are consistent with the anti-inflammatory and chondroprotective effects previously occurred in experimental studies. This new combination of integration (MSM and BS) has presented good results and satisfactory in comparison with GS, until now the cornerstone of the treatment of arthritis in according to guidelines.
© The Author(s) 2015.

Entities:  

Keywords:  boswellic acid; glucosamine; knee; methylsulfonylmethane; osteoarthritis

Mesh:

Substances:

Year:  2015        PMID: 26684635      PMCID: PMC5806735          DOI: 10.1177/0394632015622215

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  20 in total

1.  Arthroscopic validation of radiographic grading scales of osteoarthritis of the tibiofemoral joint.

Authors:  Richard Kijowski; Donna Blankenbaker; Paul Stanton; Jason Fine; Arthur De Smet
Journal:  AJR Am J Roentgenol       Date:  2006-09       Impact factor: 3.959

Review 2.  OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009.

Authors:  W Zhang; G Nuki; R W Moskowitz; S Abramson; R D Altman; N K Arden; S Bierma-Zeinstra; K D Brandt; P Croft; M Doherty; M Dougados; M Hochberg; D J Hunter; K Kwoh; L S Lohmander; P Tugwell
Journal:  Osteoarthritis Cartilage       Date:  2010-02-11       Impact factor: 6.576

3.  The algofunctional indices for hip and knee osteoarthritis.

Authors:  M G Lequesne
Journal:  J Rheumatol       Date:  1997-04       Impact factor: 4.666

4.  Indexes of severity for osteoarthritis of the hip and knee. Validation--value in comparison with other assessment tests.

Authors:  M G Lequesne; C Mery; M Samson; P Gerard
Journal:  Scand J Rheumatol Suppl       Date:  1987

5.  OARSI guidelines for the non-surgical management of knee osteoarthritis.

Authors:  T E McAlindon; R R Bannuru; M C Sullivan; N K Arden; F Berenbaum; S M Bierma-Zeinstra; G A Hawker; Y Henrotin; D J Hunter; H Kawaguchi; K Kwoh; S Lohmander; F Rannou; E M Roos; M Underwood
Journal:  Osteoarthritis Cartilage       Date:  2014-01-24       Impact factor: 6.576

6.  Effect of glucosamine sulphate on joint space narrowing, pain and function in patients with hip osteoarthritis; subgroup analyses of a randomized controlled trial.

Authors:  R M Rozendaal; E J Uitterlinden; G J V M van Osch; E H Garling; S P Willemsen; A Z Ginai; J A N Verhaar; H Weinans; B W Koes; S M A Bierma-Zeinstra
Journal:  Osteoarthritis Cartilage       Date:  2008-10-09       Impact factor: 6.576

7.  The analgetic action of dimethyl sulfoxide (DMSO) ointment in arthrosis. A double blind study.

Authors:  U Vuopala; E Vesterinen; W J Kaipainen
Journal:  Acta Rheumatol Scand       Date:  1971

Review 8.  Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!).

Authors:  F Berenbaum
Journal:  Osteoarthritis Cartilage       Date:  2012-11-27       Impact factor: 6.576

9.  A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.

Authors:  Krishanu Sengupta; Krishnaraju V Alluri; Andey Rama Satish; Simanchala Mishra; Trimurtulu Golakoti; Kadainti Vs Sarma; Dipak Dey; Siba P Raychaudhuri
Journal:  Arthritis Res Ther       Date:  2008-07-30       Impact factor: 5.156

10.  Nonsteroidal anti-inflammatory drugs and their risk: a story still in development.

Authors:  Lee S Simon
Journal:  Arthritis Res Ther       Date:  2013-07-24       Impact factor: 5.156

View more
  7 in total

Review 1.  Methylsulfonylmethane: Applications and Safety of a Novel Dietary Supplement.

Authors:  Matthew Butawan; Rodney L Benjamin; Richard J Bloomer
Journal:  Nutrients       Date:  2017-03-16       Impact factor: 5.717

2.  Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis.

Authors:  Ganpeng Yu; Wang Xiang; Tianqing Zhang; Liuting Zeng; Kailin Yang; Jun Li
Journal:  BMC Complement Med Ther       Date:  2020-07-17

3.  Dietary Ingredients Requiring Further Research Before Evidence-Based Recommendations Can Be Made for Their Use as an Approach to Mitigating Pain.

Authors:  Cindy Crawford; Courtney Boyd; Kevin Berry; Patricia Deuster
Journal:  Pain Med       Date:  2019-08-01       Impact factor: 3.750

Review 4.  An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases.

Authors:  Nand Kishor Roy; Dey Parama; Kishore Banik; Devivasha Bordoloi; Amrita Khwairakpam Devi; Krishan Kumar Thakur; Ganesan Padmavathi; Mehdi Shakibaei; Lu Fan; Gautam Sethi; Ajaikumar B Kunnumakkara
Journal:  Int J Mol Sci       Date:  2019-08-22       Impact factor: 5.923

5.  Molecular docking and in vitro analysis of phytoextracts from B. serrata for antibacterial activities.

Authors:  Ramsi Vakayil; Murugesan Anbazhagan; Gnanendra Shanmugam; Srinivasan Ramasamy; Maghimaa Mathanmohun
Journal:  Bioinformation       Date:  2021-07-31

Review 6.  Potential complementary and/or synergistic effects of curcumin and boswellic acids for management of osteoarthritis.

Authors:  Vidhu Sethi; Manohar Garg; Maxime Herve; Ali Mobasheri
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-09-22       Impact factor: 3.625

7.  Influence of the Amount of Change in Quadriceps Tendon Young's Modulus on Amount of Change in Walking Speed before and after Total Knee Arthroplasty.

Authors:  Bungo Ebihara; Hirotaka Mutsuzaki; Takashi Fukaya; Koichi Iwai
Journal:  Medicina (Kaunas)       Date:  2021-12-04       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.